Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: Flamel Technologies, S.A. (FLML)

No earlier versions found for this Subject.

Return to Flamel Technologies, S.A. (FLML)

Flamel’s systems, Micropump® for small molecules and Medusa® for proteins, allow improvements in the therapeutic characteristics, safety profile and patient compliance of many drugs.

The Company is a recognized world leader in the innovation of delivery systems for small molecule and protein drugs, providing tailored solutions to the biotech and pharmaceutical industries for optimized controlled-release delivery of drugs.
Flamel has partnership agreements with major pharmaceutical companies.

flamel.com